PBM icon

Psyence Biomedical
PBM

6 hedge funds and large institutions have $625K invested in Psyence Biomedical in 2025 Q2 according to their latest regulatory filings, with 2 funds opening new positions, 0 increasing their positions, 4 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

more capital invested

Capital invested by funds: $ → $

more ownership

Funds ownership: →

less funds holding

Funds holding: →

less first-time investments, than exits

New positions opened: | Existing positions closed:

100% less repeat investments, than reductions

Existing positions increased: 0 | Existing positions reduced: 4

Holders
6
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$462K
2
+$17.8K

Top Sellers

1
-$63.3K
2
-$45.2K
3
-$22K
4
UBS Group
UBS Group
Switzerland
-$12K
5
TSS
Two Sigma Securities
New York
-$7.76K
Name Holding Trade Value Shares
Change 		Change in
Stake
PA
1
Parallel Advisors
California
$462K
SM
2
Sabby Management
Florida
$108K
AI
3
AdvisorShares Investments
Maryland
$23.7K
Bank of America
4
Bank of America
North Carolina
$17.8K
UBS Group
5
UBS Group
Switzerland
$10.4K
SFFS
6
Stonehage Fleming Financial Services
Jersey
$2.99K
Citadel Advisors
7
Citadel Advisors
Florida
–
VF
8
Virtu Financial
New York
–
TSS
9
Two Sigma Securities
New York
–
Morgan Stanley
10
Morgan Stanley
New York
–